Research 2020
Composites AM Market Opportunities

This 170-page study from 3dpbm Research provides an in-depth analysis of each major sub-segment in composites...

Industry RoundupPress Releases

Biogelx creates scientific advisory board

Biogelx created a Scientific Advisory Board (SAB) to provide scientific review and guidance to the company regarding research and development of its peptide-based hydrogels and bioinks.

The team met for the first time on the November 19th to discuss current status and to outline the scientific and commercial direction for the company in the next twelve to eighteen months.

The SAB will be chaired by Biogelx CEO, Alison Clayton, who has over twenty-five years’ experience in the industry, gaining experiences at businesses such as Quintiles, Aptuit and Eurofins before joining Biogelx in March 2020. Ms. Clayton said that: “I am excited to be joined in the Scientific Advisory Board by such distinguished and brilliant experts in their fields, who have joined in order to provide input and insight to Biogelx’s research and development strategy moving forward. I have no doubt that this group will push the company forward in the right direction.” She went on to say that “It is important that we have members with a broad range of experience and expertise in order to provide insight from all angles.”

The members of Biogelx’s SAB are: 

Dr. Alison ClaytonBiogelx CEO. 

Prof Rein UlijnBiogelx Founder & Board member. Director of the ASRC Sensor CAT (Center for Advanced Technology), Advanced Science Research Center, City University of New York (CUNY).  

Dr Mhairi RodgersBiogelx Head of Operations. 

Prof Matthew DalbyProfessor of Cell Engineering and co-director of the Centre for the Cellular Microenvironment at the University of Glasgow and director of the EPSRC/SFI lifETIME Centre for Doctoral Training. 

Dr Manuel Salmeron-SanchezProfessor of Biomedical Engineering and co-director of the Centre for the Cellular Microenvironment at the University of Glasgow. 

Paul SmithBioAscent CEO. Senior Executive with both General Management and Business Development experience in the pharmaceutical/CRO arena. 

 

Adam Strömbergsson

Adam is a legal researcher and writer with a background in law and literature. Born in Montreal, Canada, he has spent the last decade in Ottawa, Canada, where he has worked in legislative affairs, law, and academia. Adam specializes in his pursuits, most recently in additive manufacturing. He is particularly interested in the coming international and national regulation of additive manufacturing. His past projects include a history of his alma mater, the University of Ottawa. He has also specialized in equity law and its relationship to judicial review. Adam’s current interest in additive manufacturing pairs with his knowledge of historical developments in higher education, copyright and intellectual property protections.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!